Literature DB >> 25588575

Aiding a reassertion of self: a qualitative study of the views and experiences of women with ovarian cancer receiving long-term nurse-led telephone follow-up.

Anna Cox1, Sara Faithfull.   

Abstract

PURPOSE: This study explored the views and experiences of women following treatment for ovarian cancer who had received long-term (at least 3 years) nurse-led telephone follow-up. Exploring the long-term experiences of follow-up for women with ovarian cancer provides important information regarding the coping processes of cancer survivors that can inform the development of innovative and patient-centred approaches of cancer follow-up.
METHODS: This is a qualitative study approach using interpretative phenomenological analysis (IPA). Eleven women were identified by a clinical nurse specialist as having received nurse-led telephone follow-up for a period of at least 3 years. These women were interviewed in person or over the telephone using a semi-structured interview schedule; interviews were audio-recorded and transcriptions were analysed using IPA.
RESULTS: Nurse-led telephone follow-up was felt to support a reassertion of self and a rejection of patient identity. Three core themes emerged regarding the positive impact of nurse-led telephone follow-up: 'Somebody was looking out for me' highlights the perception of increased psychosocial support; 'It's just reassurance' includes both the deep trust in the expertise of the nurse and the reassurance of the continued blood tests; and 'Time was never an issue' presents the perception of relaxed follow-up appointments with time to talk and the perceived practical benefits of this approach.
CONCLUSIONS: Nurse-led telephone follow-up was broadly recommended for women following treatment for ovarian cancer, particularly for those later on in the survivorship trajectory when focus may move from biomedical aspects of cure to holistic approaches to well-being. Remote interventions which provide a perception of a consistent and constant source of medical and psychosocial support may support adaption to cancer survivorship by enabling a reassertion of self and a rejection of patient identity.

Entities:  

Mesh:

Year:  2015        PMID: 25588575     DOI: 10.1007/s00520-014-2578-4

Source DB:  PubMed          Journal:  Support Care Cancer        ISSN: 0941-4355            Impact factor:   3.603


  9 in total

1.  Telephone follow-up after treatment for breast cancer: views and experiences of patients and specialist breast care nurses.

Authors:  Kinta Beaver; Susan Williamson; Karen Chalmers
Journal:  J Clin Nurs       Date:  2010-10       Impact factor: 3.036

Review 2.  Survivorship programs and care planning.

Authors:  Mary S McCabe; Sara Faithfull; Wendy Makin; Yvonne Wengstrom
Journal:  Cancer       Date:  2013-06-01       Impact factor: 6.860

3.  A grounded theory approach to understand the cancer-coping process.

Authors:  Vikki Knott; Deborah Turnbull; Ian Olver; Anthony Winefield
Journal:  Br J Health Psychol       Date:  2011-10-07

4.  Finding a new normal: a grounded theory study of rehabilitation after treatment for upper gastrointestinal or gynaecological cancers--the patient's perspective.

Authors:  C Sandsund; N Pattison; N Doyle; C Shaw
Journal:  Eur J Cancer Care (Engl)       Date:  2012-11-19       Impact factor: 2.520

5.  The acceptability of e-technology to monitor and assess patient symptoms following palliative radiotherapy for lung cancer.

Authors:  Anna Cox; Marianne Illsley; Wendy Knibb; Caroline Lucas; Michael O'Driscoll; Claire Potter; Adrian Flowerday; Sara Faithfull
Journal:  Palliat Med       Date:  2011-04-07       Impact factor: 4.762

6.  A preliminary study of patients' perceptions of routine follow-up after treatment for breast cancer.

Authors:  E Pennery; J Mallet
Journal:  Eur J Oncol Nurs       Date:  2000-09       Impact factor: 2.398

7.  Patients' perceptions and experiences of using a mobile phone-based advanced symptom management system (ASyMS) to monitor and manage chemotherapy related toxicity.

Authors:  L McCann; R Maguire; M Miller; N Kearney
Journal:  Eur J Cancer Care (Engl)       Date:  2009-03       Impact factor: 2.520

8.  Nurse led telephone follow up in ovarian cancer: a psychosocial perspective.

Authors:  Anna Cox; Ellen Bull; Jane Cockle-Hearne; Wendy Knibb; Claire Potter; Sara Faithfull
Journal:  Eur J Oncol Nurs       Date:  2008-10-08       Impact factor: 2.398

9.  Gynaecological cancer follow-up: national survey of current practice in the UK.

Authors:  Simon Leeson; Nick Stuart; Yvonne Sylvestre; Liz Hall; Rhiannon Whitaker
Journal:  BMJ Open       Date:  2013-07-24       Impact factor: 2.692

  9 in total
  5 in total

1.  A psychosocial oncology program: perceptions of the telephone-triage assessment.

Authors:  France Desrochers; Erin Donivan; Anita Mehta; Andréa Maria Laizner
Journal:  Support Care Cancer       Date:  2016-02-05       Impact factor: 3.603

2.  'We do need to keep some human touch'-Patient and clinician experiences of ovarian cancer follow-up and the potential for an electronic patient-reported outcome pathway: A qualitative interview study.

Authors:  Fiona Kennedy; Leanne Shearsmith; Marie Holmes; Rosemary Peacock; Oana C Lindner; Molly Megson; Galina Velikova
Journal:  Eur J Cancer Care (Engl)       Date:  2022-02-10       Impact factor: 2.328

Review 3.  Cancer Survivors' Experience With Telehealth: A Systematic Review and Thematic Synthesis.

Authors:  Anna Cox; Grace Lucas; Afrodita Marcu; Marianne Piano; Wendy Grosvenor; Freda Mold; Roma Maguire; Emma Ream
Journal:  J Med Internet Res       Date:  2017-01-09       Impact factor: 5.428

4.  Electronic patient-reported monitoring of symptoms during follow-up of ovarian cancer patients: a feasibility study.

Authors:  Fiona Kennedy; Leanne Shearsmith; Marie Holmes; Zoe Rogers; Rob Carter; Uschi Hofmann; Galina Velikova
Journal:  BMC Cancer       Date:  2022-07-02       Impact factor: 4.638

5.  The role of empathic nursing telephone interventions with advanced cancer patients: A qualitative study.

Authors:  I Torres-Vigil; M Z Cohen; R M Million; E Bruera
Journal:  Eur J Oncol Nurs       Date:  2020-11-02       Impact factor: 2.398

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.